Related Experiment Video
Updated: Aug 7, 2026
09:45
Modification and Functionalization of the Guanidine Group by Tailor-made Precursors
Published on: April 27, 2017
N-Methylated cyclic RGD peptides as highly active and selective alpha(V)beta(3) integrin antagonists
M A Dechantsreiter1, E Planker, B Mathä
1Institut für Organische Chemie und Biochemie, Technische Universität München, Lichtenbergstrasse 4, D-85747 Garching, Germany.
Journal of Medicinal Chemistry
|August 17, 1999
Summary
N-methylation of the alpha(V)beta(3) integrin antagonist cyclo(RGDfV) created a more potent compound, cyclo(RGDf-N(Me)V-). This discovery offers a promising new avenue for targeting tumor metastasis and angiogenesis.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- The alpha(V)beta(3) integrin receptor is crucial in human tumor metastasis and angiogenesis.
- Inhibiting this receptor with antibodies or RGD-containing peptides shows therapeutic potential.
Purpose of the Study:
- To investigate the impact of N-methylation on the biological activity of the alpha(V)beta(3) antagonist cyclo(RGDfV).
- To identify more potent and selective inhibitors for targeting alpha(V)beta(3) integrin-mediated diseases.
Main Methods:
- Synthesis and biological evaluation of N-methylated cyclo(RGDfV) analogs.
- Nuclear Magnetic Resonance (NMR) spectroscopy for structural determination.
- Distance geometry and molecular dynamics calculations for 3D structure analysis in water.
Main Results:
- Cyclo(RGDf-N(Me)V-) (P5) demonstrated enhanced activity compared to the parent compound cyclo(RGDfV) (L1).
- P5 is identified as a highly active and selective inhibitor of vitronectin binding to alpha(V)beta(3) integrin.
- The study elucidated the high-resolution 3D structure of P5 in water.
Conclusions:
- N-methylation of cyclo(RGDfV) significantly enhances its biological activity and selectivity as an alpha(V)beta(3) integrin antagonist.
- The detailed structural insights contribute to understanding structure-activity relationships for developing novel anti-cancer therapeutics.
- This research provides a foundation for future drug development targeting alpha(V)beta(3) integrin in cancer therapy.
Related Concept Videos
01:10Integrins
Animal and protozoan cells do not have cell walls to help maintain shape and provide structural stability. Instead, these eukaryotic cells secrete a sticky mass of carbohydrates and proteins into the spaces between adjacent cells. This network of proteins and molecules is called an extracellular matrix or ECM.
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
01:15Activation of Integrins
Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.
01:17Intracellular Signaling Affects Focal Adhesions
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
01:31Immunoglobulin-like Cell Adhesion Molecules
Immunoglobulin-like cell adhesion molecules or Ig-CAMs are a versatile group of cell surface glycoproteins belonging to the immunoglobulin protein superfamily. Ig-CAMs possess the characteristic immunoglobulin protein domains and other domains such as the fibronectin type III domain. The Ig domains are glycosylated to varying degrees in different Ig-CAMs.
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...